Valuation: Rapid Micro Biosystems, Inc.

Market Cap 51.66M 45.5M 43.11M 38.92M 73.35M 4.95B 74.29M 516M 198M 2.53B 194M 190M 8.12B P/E 2026 *
-1.09x
P/E 2027 * -1.44x
Enterprise Value 51.66M 45.5M 43.11M 38.92M 73.35M 4.95B 74.29M 516M 198M 2.53B 194M 190M 8.12B EV / Sales 2026 *
1.32x
EV / Sales 2027 * 1.12x
Free-Float
81.07%
Yield 2026 *
-
Yield 2027 * -
1 day-4.63%
1 week-7.21%
1 month-32.24%
3 months-40.46%
6 months-54.63%
Current year-64.48%
1 week 1.03
Extreme 1.03
1.18
1 month 1.03
Extreme 1.03
1.53
Current year 1.03
Extreme 1.03
4.94
1 year 1.03
Extreme 1.03
4.94
3 years 0.58
Extreme 0.58
4.94
5 years 0.58
Extreme 0.58
22.71
10 years 0.58
Extreme 0.58
27.04
Manager TitleAgeSince
Chief Executive Officer 57 2014-09-30
Director of Finance/CFO 56 2018-09-30
Chief Tech/Sci/R&D Officer - 2025-04-30
Director TitleAgeSince
Director/Board Member 56 2018-09-30
Director/Board Member 57 2014-09-30
Director/Board Member 77 2016-03-14
Date Insider Type Main position Quantity % Market Cap. Importance
7/24/26 Exercice

Director

7,016 0.0155%
7/22/26 Exercice

Chief Executive Officer

2,804 0.0062%
5/29/26 Free

Director

38,361 0.0921%
Change 5-day change 1-year change 3-year change Capi.($)
-4.63%-7.21%-69.16%-4.63% 54.17M
-0.67%+1.47%+39.18%+33.36% 251B
-1.84%-0.00%+11.75%-10.70% 159B
-1.35%+2.09%-9.08%+39.12% 146B
-0.52%-2.17%-55.29%-17.33% 63.59B
-2.00%-0.58%+10.99%+24.60% 50.77B
-1.55%+4.23%+34.25%+54.10% 49.35B
-1.76%+2.07%-17.49%-20.90% 48.75B
+2.47%+5.43%-4.18%+40.30% 45.1B
-0.87%+4.47%+46.56%+60.24% 43.55B
Average -1.27%+1.10%-1.25%+19.82% 85.7B
Weighted average by Cap. -1.03%+1.94%+11.79%+21.72%

Financials

2026 *2027 *
Net sales 39.28M 34.59M 32.77M 29.59M 55.76M 3.77B 56.48M 392M 151M 1.93B 147M 144M 6.17B 46.32M 40.79M 38.65M 34.89M 65.76M 4.44B 66.61M 462M 178M 2.27B 174M 170M 7.28B
Net income -44.9M -39.54M -37.46M -33.82M -63.74M -4.31B -64.57M -448M -172M -2.2B -169M -165M -7.06B -35.9M -31.61M -29.95M -27.04M -50.97M -3.44B -51.62M -358M -138M -1.76B -135M -132M -5.64B
Net Debt - -
Logo Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc. is an innovative life sciences technology company that enables the safe manufacture of pharmaceutical products through its rapid automated microbial quality control (MQC) detection platform. The Company develops, manufactures, markets and sells the Growth Direct system and related proprietary consumables, and value-added services to enable rapid MQC testing in the manufacture of biologics and cell and gene therapies, vaccines, sterile injectables, and other healthcare products. Its Growth Direct platform comprises the Growth Direct system, optional laboratory information management system (LIMS) connection software, proprietary consumables, and comprehensive field service, validation services and post-warranty service contracts. Its technology fully automates and digitizes the process of pharmaceutical MQC and is designed to enable its customers to perform this critical testing process accurately and securely.
Employees
171
Date Price Change Volume
26-09-30 US$1.030 -4.63% 179,895
26-09-29 US$1.080 -1.37% 334,268
26-09-28 US$1.095 -1.35% 268,313
26-09-25 US$1.110 -.--% 171,620
26-09-24 US$1.110 -.--% 504,370
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.030USD
Average target price
5.750USD
Spread / Average Target
+458.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RPID Stock